These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2894290)

  • 1. Epidemiological survey of the use and abuse of agonist-antagonist analgesics in the Western Pacific region.
    Navaratnam V
    Drug Alcohol Depend; 1987 Dec; 20(4):367-73. PubMed ID: 2894290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical observations of agonist-antagonist analgesic dependence.
    Peachey JE
    Drug Alcohol Depend; 1987 Dec; 20(4):347-65. PubMed ID: 2894289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of epidemiological data on agonist-antagonist analgesics.
    Ghodse AH
    Drug Alcohol Depend; 1987 Dec; 20(4):375-83. PubMed ID: 3440438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review of drug abuse and measures to reduce the illicit demand for drugs by region. Division of Narcotic Drugs of the United Nations Secretariat.
    Bull Narc; 1987; 39(1):3-30. PubMed ID: 2441786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.
    Gilson AM; Ryan KM; Joranson DE; Dahl JL
    J Pain Symptom Manage; 2004 Aug; 28(2):176-88. PubMed ID: 15276196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recreational drug use in the Asia Pacific region: improvement in our understanding of the problem through the UNODC programmes.
    Dargan PI; Wood DM
    J Med Toxicol; 2012 Sep; 8(3):295-9. PubMed ID: 22569822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of illicit drug use in Asia and the Pacific.
    Devaney ML; Reid G; Baldwin S
    Drug Alcohol Rev; 2007 Jan; 26(1):97-102. PubMed ID: 17364842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables.
    Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD
    Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysubstance use and misuse or abuse of prescription opioid analgesics: a multi-level analysis of international data.
    Morley KI; Ferris JA; Winstock AR; Lynskey MT
    Pain; 2017 Jun; 158(6):1138-1144. PubMed ID: 28267061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Abuse Among the Elderly: Implications for Dental Practice.
    Ng KF; Ouanounou A
    Compend Contin Educ Dent; 2018 Mar; 39(3):159-163; quiz 164. PubMed ID: 29493245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Misconceptions and Realities of the Prescription Opioid Epidemic.
    Schnoll SH
    Clin Pharmacol Ther; 2018 Jun; 103(6):963-965. PubMed ID: 29464692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug abuse and public health. A global perspective.
    Senay EC
    Drug Saf; 1991; 6 Suppl 1():1-65. PubMed ID: 2021427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
    Ferrara MM
    Seton Hall Law Rev; 2012; 42(2):741-67. PubMed ID: 22708140
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study.
    Berterame S; Erthal J; Thomas J; Fellner S; Vosse B; Clare P; Hao W; Johnson DT; Mohar A; Pavadia J; Samak AK; Sipp W; Sumyai V; Suryawati S; Toufiq J; Yans R; Mattick RP
    Lancet; 2016 Apr; 387(10028):1644-56. PubMed ID: 26852264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dependence characteristics and risk assessment of agonist-antagonist analgesics.
    Yanagita T
    Drug Alcohol Depend; 1987 Dec; 20(4):317-27. PubMed ID: 2894286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of the switch from buprenorphine to buprenorphine/naloxone in an Italian addiction treatment centre.
    Stimolo C; Favero VD; Zecchinato G; Buson R; Cusin D; Pellachin P; Simonetto P
    Clin Drug Investig; 2010; 30 Suppl 1():27-31. PubMed ID: 20450243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicines and the drug control treaties: is buprenorphine for opioid addiction at risk of being lost?
    Costa E Silva JA
    Hum Psychopharmacol; 2004 Jun; 19(4):215-24. PubMed ID: 15181649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benefit-risk ratio of agonist-antagonist analgesics.
    Lasagna L
    Drug Alcohol Depend; 1987 Dec; 20(4):385-93. PubMed ID: 2894291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO Symposium on Drug Dependence: Benefit-risk ratio assessment of agonist-antagonist analgesics. August 1986. Satellite meeting to the III World Conference on Clinical Pharmacology and Therapeutics.
    Drug Alcohol Depend; 1987 Dec; 20(4):289-399. PubMed ID: 2894284
    [No Abstract]   [Full Text] [Related]  

  • 20. The global diversion of pharmaceutical drugs
non-medical use and diversion of psychotropic prescription drugs in North America: a review of sourcing routes and control measures.
    Fischer B; Bibby M; Bouchard M
    Addiction; 2010 Dec; 105(12):2062-70. PubMed ID: 20840172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.